An Australian stem cell and regenerative medicine company
February 06, 2025
February 2025 Investor Webinar
Today, Cynata's CEO and MD, Dr Kilian Kelly and CBO Dr Mathias Kroll, provided an update to investors, following the release of the ASX Quarterly Activity Report for the December 2024 quarter.